Current diagnostic methods fail to quantify the systemic impact of localized microbial inflammation and salivary dysfunction. Precise identification of these pathological states allows for early intervention before tissue degradation occurs.

Standard testing lacks the throughput and precision to quantify how effectively oral hygiene products overcome microbial attachment forces. Solving this allows for objective benchmarking of product efficacy against persistent biological layers.